Chiara Cremolini, MD, PhD
Unit of Medical Oncology 2
Azienda Ospedaliero-Universitaria Pisana
Department of Translational Research and New Technologies in Medicine and Surgery
University of Pisa
Chiara Cremolini, MD, PhD, has disclosed that she has received funds for research support from Amgen, Bayer, and Merck and consulting fees from Bayer, Merck, MSD, Nordic Pharma, Pierre Fabre, and Roche.
Teresa Macarulla, MD
Vall d Hebron Institute of Oncology
Teresa Macarulla, MD, has disclosed that she has received consulting fees from Ability, Advance Medical HCMS, AstraZeneca, Baxter, Celgene, Eisai, Genzyme, Incyte, Ispen, Lilly, Marketing Farmacéutico & Investigación Clínica SL, Merck Sharp and Dohme, QED, Roche, Sanofi, Servier, and Zymeworks.